An Inhaled Galectin-3 Inhibitor in COVID-19 Pneumonitis (DEFINE): A Phase Ib/IIa Randomised Controlled Trial. Gaughan EE, Quinn TM, Mills A, Bruce AM, et al. Am J Respir Crit Care Med 2022 Aug 16. doi: 10.1164/rccm.202203-0477.

Read + Share

Amedeo Smart

Independent Medical Education

Gaughan EE, Quinn TM, Mills A, Bruce AM, et al. An Inhaled Galectin-3 Inhibitor in COVID-19 Pneumonitis (DEFINE): A Phase Ib/IIa Randomised Controlled Trial. Am J Respir Crit Care Med 2022 Aug 16. doi: 10.1164/rccm.202203-0477.
PMID: 35972987